Associations between Bethesda categories and tumor characteristics of conventional papillary thyroid carcinoma
Vivian Youngjean Park, Eun-Kyung Kim, Jin Young Kwak, Jung Hyun Yoon, Hee Jung Moon
Ultrasonography. 2018;37(4):323-329. Published online 2017 Nov 22 DOI: https://doi.org/10.14366/usg.17053
Citations to this article as recorded by 
Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules
Mayumi Endo, Jing Peng, Fadi A Nabhan, Pamela Brock, Irina Azaryan, Clarine Long, Laura E Ryan, Matthew D Ringel, Jennifer A Sipos
The Journal of Clinical Endocrinology & Metabolism.2024;[Epub] CrossRef
Cytological and Ultrasound Features of Thyroid Nodules Correlate With Histotypes and Variants of Thyroid Carcinoma
Daniele Sgrò, Alessandro Brancatella, Giuseppe Greco, Liborio Torregrossa, Paolo Piaggi, Nicola Viola, Teresa Rago, Fulvio Basolo, Riccardo Giannini, Gabriele Materazzi, Rossella Elisei, Ferruccio Santini, Francesco Latrofa
The Journal of Clinical Endocrinology & Metabolism.2023; 108(11): e1186. CrossRef
Taraxasterol inhibits TGF-β1-induced epithelial-to-mesenchymal transition in papillary thyroid cancer cells through regulating the Wnt/β-catenin signaling
J Zhu, X Li, S Zhang, J Liu, X Yao, Q Zhao, B Kou, P Han, X Wang, Y Bai, Z Zheng, C Xu
Human & Experimental Toxicology.2021; 40(12_suppl): S87. CrossRef
Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?
Sena Turkdogan, Marc Pusztaszeri, Veronique-Isabelle Forest, Michael P. Hier, Richard J. Payne
Cancers.2020; 12(9): 2563. CrossRef